Adrenomyeloneuropathy: Difference between revisions

Jump to navigation Jump to search
WikiBot (talk | contribs)
m Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +)
Irfan Dotani (talk | contribs)
No edit summary
 
Line 1: Line 1:
__NOTOC__
{{SI}}
{{SI}}
{{CMG}}; {{AE}}


==Overview==
'''Adrenomyeloneuropathy''' is a rare [[inherited disorder]]. It is a form of X-linked [[adrenoleukodystrophy]]. [[Leukodystrophy]] causes a disruption to the [[myelin]] sheath that covers and protects [[nerve]]s. Prognosis is normally poor and death usually occurs within a few years after onset.
==Historical Perspective==
==Classification==
==Pathophysiology==
==Causes==
==Differentiating {{PAGENAME}} from Other Diseases==


'''Adrenomyeloneuropathy''' is a rare [[inherited disorder]]. It is a form of X-linked [[adrenoleukodystrophy]]. [[Leukodystrophy]] causes a disruption to the [[myelin]] sheath that covers and protects [[nerve]]s. Prognosis is normally poor and death usually occurs within a few years after onset.
==Epidemiology and Demographics==
 
==Risk Factors==
 
==Screening==
 
==Natural History, Complications, and Prognosis==
 
==Diagnosis==
===Diagnostic Criteria===
 
===History and Symptoms===
 
===Physical Examination===
 
===Laboratory Findings===
 
===Imaging Findings===
 
===Other Diagnostic Studies===
 
==Treatment==
===Medical Therapy===
 
===Surgery===


== References ==
===Prevention===


==Other Sources==
*[http://www.cmaj.ca/cgi/content/full/171/9/1073 Canada Medical Journal]
*[http://www.cmaj.ca/cgi/content/full/171/9/1073 Canada Medical Journal]
*[http://www.ninds.nih.gov/disorders/adrenoleukodystrophy/adrenoleukodystrophy.htm National institute of Neurological Disorder and Stroke]
*[http://www.ninds.nih.gov/disorders/adrenoleukodystrophy/adrenoleukodystrophy.htm National institute of Neurological Disorder and Stroke]


==References==
{{reflist|2}}


 
[[Category:Endocarniology]]


{{WH}}
{{WH}}
{{WS}}
{{WS}}

Latest revision as of 17:50, 22 July 2016

WikiDoc Resources for Adrenomyeloneuropathy

Articles

Most recent articles on Adrenomyeloneuropathy

Most cited articles on Adrenomyeloneuropathy

Review articles on Adrenomyeloneuropathy

Articles on Adrenomyeloneuropathy in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Adrenomyeloneuropathy

Images of Adrenomyeloneuropathy

Photos of Adrenomyeloneuropathy

Podcasts & MP3s on Adrenomyeloneuropathy

Videos on Adrenomyeloneuropathy

Evidence Based Medicine

Cochrane Collaboration on Adrenomyeloneuropathy

Bandolier on Adrenomyeloneuropathy

TRIP on Adrenomyeloneuropathy

Clinical Trials

Ongoing Trials on Adrenomyeloneuropathy at Clinical Trials.gov

Trial results on Adrenomyeloneuropathy

Clinical Trials on Adrenomyeloneuropathy at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Adrenomyeloneuropathy

NICE Guidance on Adrenomyeloneuropathy

NHS PRODIGY Guidance

FDA on Adrenomyeloneuropathy

CDC on Adrenomyeloneuropathy

Books

Books on Adrenomyeloneuropathy

News

Adrenomyeloneuropathy in the news

Be alerted to news on Adrenomyeloneuropathy

News trends on Adrenomyeloneuropathy

Commentary

Blogs on Adrenomyeloneuropathy

Definitions

Definitions of Adrenomyeloneuropathy

Patient Resources / Community

Patient resources on Adrenomyeloneuropathy

Discussion groups on Adrenomyeloneuropathy

Patient Handouts on Adrenomyeloneuropathy

Directions to Hospitals Treating Adrenomyeloneuropathy

Risk calculators and risk factors for Adrenomyeloneuropathy

Healthcare Provider Resources

Symptoms of Adrenomyeloneuropathy

Causes & Risk Factors for Adrenomyeloneuropathy

Diagnostic studies for Adrenomyeloneuropathy

Treatment of Adrenomyeloneuropathy

Continuing Medical Education (CME)

CME Programs on Adrenomyeloneuropathy

International

Adrenomyeloneuropathy en Espanol

Adrenomyeloneuropathy en Francais

Business

Adrenomyeloneuropathy in the Marketplace

Patents on Adrenomyeloneuropathy

Experimental / Informatics

List of terms related to Adrenomyeloneuropathy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Adrenomyeloneuropathy is a rare inherited disorder. It is a form of X-linked adrenoleukodystrophy. Leukodystrophy causes a disruption to the myelin sheath that covers and protects nerves. Prognosis is normally poor and death usually occurs within a few years after onset.

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Adrenomyeloneuropathy from Other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications, and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Other Sources

References

Template:WH Template:WS